[Treatment of oligometastatic or oligoprogression cancer].

C Bourgier, I Latorzeff, P Fenoglietto, P Boisselier, M Charissoux, C Llacer,C Lemanski,O Riou,M-P Farcy-Jacquet, D Azria

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique（2019）

引用 1|浏览36

暂无评分

摘要

We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival, and to identify the place of SBRT in patient's pathway.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要